![Helen Roberts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Helen Roberts
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Kira Biotech Pty Ltd.
![]() Kira Biotech Pty Ltd. BiotechnologyHealth Technology Kira Biotech Pty Ltd. operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders. The company was founded by Georgina Clark is headquartered in Brisbane, Australia.
8
| Holding Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Helen Roberts
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
OneVentures Management Pty Ltd.
![]() OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures Management Pty Ltd. (OneVentures) is a venture capital firm, a susbidiary of Andover Group Pty Ltd was founded in 2006 by Dr Michelle Deaker. The firm is headquartered in Australia. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
Gettysburg College | College/University | Undergraduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
Medicines Australia
![]() Medicines Australia Pharmaceuticals: MajorHealth Technology Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia. | Pharmaceuticals: Major | Consultant / Advisor | |
CERA Technologies Pty Ltd.
![]() CERA Technologies Pty Ltd. Packaged SoftwareTechnology Services Part of Revenio Group Oyj, CERA Technologies Pty Ltd. is a world-leading eye care platform that connects ophthalmology, optometry, primary care, emergency rooms, and patients to share clinical information and enhance referrals, triage, and collaborative care. The company is based in Melbourne, Australia. The technology enhances collaboration, bridges disconnected data silos, and delivers fast, efficient patient care. The platform is designed to share clinical correspondence securely and instantly between health care professionals, addressing the known challenges in clinical communication between a collaborative care network of health care providers. The company complies with the data protection regulations of HIPAA, the GDPR, and the Australian Privacy Principles. The company was founded in 2015 by Kate Taylor, Jonathan Crowston. Kate Taylor has been the CEO since 2015. CERA Technologies was acquired by Revenio Group Oyj on April 27, 2021 for $14.42 million. | Packaged Software | Director/Board Member | |
ProTA Therapeutics Pty Ltd.
![]() ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology ProTA Therapeutics Pty Ltd. manufactures pharmaceutical products. The company was founded by Mimi Tang on September 23, 2016 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
Genome One Pty Ltd. | Chief Executive Officer | ||
University of Tennessee | College/University | Undergraduate Degree | |
TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amgen AB
![]() Amgen AB BiotechnologyHealth Technology Amgen AB conducts biotechnology research and experimental development. It focuses on the following therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. The company was founded in 1980 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
OMICO CORPORATION | Real Estate Development | Corporate Officer/Principal | |
Oculo Therapy LLC
![]() Oculo Therapy LLC Miscellaneous Commercial ServicesCommercial Services Oculo Therapy LLC is an American biotechnology company. | Miscellaneous Commercial Services | Director/Board Member | |
Pacific Equity Partners Pty Ltd.
![]() Pacific Equity Partners Pty Ltd. Investment ManagersFinance Pacific Equity Partners Pty Ltd (Pacific Equity Partners) is a private equity firm founded in 1998. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor | |
THE GPT GROUP | Real Estate Investment Trusts | Corporate Officer/Principal | |
The Carlyle Group Pty Ltd.
![]() The Carlyle Group Pty Ltd. Investment ManagersFinance The Carlyle Group Pty Ltd. provides investment services. The company was founded on May 24, 1996 and is headquartered in Sydney, Australia. | Investment Managers | Corporate Officer/Principal | |
Goldman Sachs International Ltd. (Market-Maker) | Financial Conglomerates | Corporate Officer/Principal | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
Envisagenics, Inc.
![]() Envisagenics, Inc. BiotechnologyHealth Technology Envisagenics, Inc. engages in developing of artificial intelligence platform for discovering drugs. The company was founded by Maria Luisa Pineda and Martin Akerman and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
AKARI THERAPEUTICS, PLC | Biotechnology | Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree | |
The University of Queensland | College/University | Undergraduate Degree | |
Axial Therapeutics, Inc.
![]() Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Hadean Ventures AS
![]() Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor | |
Molecular Warehouse Ltd.
![]() Molecular Warehouse Ltd. Medical SpecialtiesHealth Technology Molecular Warehouse Ltd. develops proteins for diagnostics and therapeutics. The company was founded by Siro Perez, Kirill Alexandrov and Nikita Alexandrov and is headquartered in Oxford, the United Kingdom. | Medical Specialties | Chief Executive Officer | |
Ankere Therapeutics
![]() Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Juniata College | College/University | Undergraduate Degree | |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Director/Board Member | |
Fox School of Business | College/University | Masters Business Admin | |
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Atrin Pharmaceuticals LLC
![]() Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member | |
Atrin Pharmaceuticals, Inc.
![]() Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Pharmaceuticals: Major | Director/Board Member | |
APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nokia Services Ltd.
![]() Nokia Services Ltd. Specialty TelecommunicationsCommunications Nokia Services Ltd. develops applications and network products and services across Australia and New Zealand. The company is headquartered in Rhodes, New South Wales. | Specialty Telecommunications | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 18 |
Australien | 13 |
Vereinigtes Königreich | 3 |
Belgien | 2 |
Schweden | 2 |
Sektoral
Health Technology | 19 |
Finance | 8 |
Consumer Services | 8 |
Technology Services | 2 |
Commercial Services | 2 |
Operativ
Director/Board Member | 20 |
Corporate Officer/Principal | 10 |
Undergraduate Degree | 5 |
Independent Dir/Board Member | 5 |
Private Equity Investor | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Michael Grissinger | 12 |
Kelly Constable | 11 |
Sarah J. Meibusch | 6 |
Jen Vaneris | 6 |
Siro Perez | 4 |
Dan Baker | 4 |
Dan Baker | 4 |
Georgina Clark | 1 |
- Börse
- Insiders
- Helen Roberts
- Unternehmensverbindungen